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Summary.-The cytolethal response to treatment with prednisolone was investi-
gated in vitro in eight human lymphoblastoid cell lines containing varying concen-
trations of specific cytoplasmic glucocorticoid receptors. A similar response was
observed in seven of the lines irrespective of their concentration of cytoplasmic
receptors, and pharmacological doses of steroid, well above those required to saturate
receptors in cell-free extracts, were required for a massive lethal response. One
cell line derived from Burkitt's lymphoma was refractory to lethal effects even with
pharmacological doses of steroid.
A similar unresponsiveness to the cytolethal effect of prednisolone in vitro was
observed in fresh lymphoblasts derived from patients with acute lymphoblastic
leukaemia despite evidence of a satisfactory clinical response to therapy which in-
cluded steroid. The resistance of human lymphoblastoid cells to treatment with
glucocorticoids in vitro may result from a defect in activation subsequent to the
binding of steroid to cytoplasmic receptors.
THE cytolethal effects of gluco-
corticoid hormones on normal and neo-
plastic lymphoid cells are well established
(Dougherty, 1952; Harris, 1970; Rosenau
et al., 1972). Moreover, in combination
with other drugs, glucocorticoid hormones
are highly effective in the treatment of
acute lymphoblastic leukaemia (ALL) of
man (Simone, 1974). At the molecular
level, however, the precise mode of
action of glucocorticoid hormones on
lymphoid cells has still to be resolved.
It is generally held that binding of
steroid to specific protein receptor mole-
cules in the cytoplasm is the first step
in the cytolytic process in sensitive cells.
Subsequently, steroid-receptor complexes
are believed to undergo a temperature-
dependent conformational change and
migrate to the nucleus, where they
influence transcriptional activity in such
a way that cell lysis results (Munck et
al., 1972; Higgins et al., 1973; Thompson
and Lippman, 1974).
However, much of the current state
of knowledge concerning the mechanism
of glucocorticoid hormone action is based
on experiments with rodent tissues, in-
cluding thymocytes and various cultured
cell lines. Little is known of these
events in human lymphoid cells and, in
particular, the role of cytoplasmic re-
ceptors in the initiation of hormone
effects appears uncertain. In one study
(Lippman et al., 1973) with freshly isolated
lymphoblasts from patients with ALL, a
close correlation was found between hor-
mone responsiveness in vivo and the
concentration of cytoplasmic receptors.
However, other studies (Gailani et al.,
1973; Lippman, Perry and Thompson,
1974) with 3 lymphoblastoid cell lines in
vitro, failed to reveal such an association
and the role of cytoplasmic receptors in
the initiation of cytolethal effects by
glucocorticoids in human cells remains to
be established.
To investigate this problem, we haveGLUCOCORTICOID RECEPTORS IN HUMAN LYMPHOBLASTOID CELLS
studied the relationship of cytoplasmic
receptor levels and glucocorticoid cyto-
lethal effects in a series ofhuman lympho-
blastoid cell lines derived from patients
with leukaemia or lymphoma, or without
malignant disease.
MATERIALS AND METHODS
Cell lines.-The cell lines were derived
from freshly isolated human lymphoid cells
of lymph glands, lymphoid tumours or
peripheral blood. They were established as
permanent cell lines in suspension culture,
either spontaneously or by a process of
co-cultivation with lethally irradiated cells
containing Epstein-Barr virus (EBV) as
described previously (Pulvertaft, 1965; Jen-
sen et al., 1967; Steel and Edmond, 1971;
Steel, 1972). Previous studies have shown
these cells to have the characteristics of B
lymphocytes by their ability to synthesize
immunoglobulins (Evans, Steel and Arthur,
1974), to have C13 receptors on their surface
membranes (Moore and Minowada, 1973),
to lack receptors for sheep red blood cells
(Evans, Smith and Steel, 1975) and to be
devoid of cytotoxic activity (Steel et al.,
1974).
Cell culture.-Cells were grown in suspen-
sion in conical glass flasks or roller culture
bottles in Eagle's minimum essential medium
(MEM, Gibco Biocult), or Ham's FIO
medium with 10% tryptose phosphate broth
(Gibco Biocult), supplemented with 20%
heat-inactivated (56°C for 1 h) foetal calf
serum (FCS, Gibco Biocult), at 3700 in a
humidified atmosphere of 5% C02 in air.
They were maintained at densities between
3 and 10 x 105/ml by feedingf with fresh
medium every 3-4 days.
Chromosome analysis.-Approximately
2 x 106 viable cells were resuspended in
5 ml of fresh growth medium. After 24 h,
a drop of 0 02% dimethylcolchicine was
added to the culture and the incubation
continued at 3700 for a further 60-90 min.
The cells were harvested by centrifugation,
exposed to 0 0075 mol/l KCI for 10 min
and fixed in 3 changes of methanol: glacial
acetic acid (3: 1, v/v). Drops of the fixed
suspension were allowed to dry on clean
slides, stained for 8 min in 0.5% quinacrine
dihydrochloride, washed for 5 min in running
water, mounted in distilled water under a
sealed coverslip and examined with a Leitz
Ortholux microscope with Ploem's vertical
illumination using an HBO 200 u.v. source.
Most cell lines have been examined repeatedly
at intervals of a few months, and from
6 to 30 metaphase spreads photographed and
fully analysed on each occasion.
Steroid binding by cell extracts.-The
binding ofglucocorticoid hormones to specific
high affinity cytoplasmic receptors was
studied by the competitive binding assay
developed by Baxter and Tomkins (1971)
using radioactively labelled and unlabelled
dexamethasone. 3-5 x 108 cells were har-
vested by centrifugation (800 g for 10 min),
washed twice in phosphate buffered saline
(PBS; 0-025 mol/l KH2PO4, 0.1 mol/l
NaCl, pH 7.4) at 0-4CC, recentrifuged and
homogenized in ice-cold tricine buffer (0-02
mol/l tricine, 0-002 mol/l CaCl2, 0001 mol/l
MgCl2, pH 7.4). Rat thymuses were excised
aseptically, rinsed in ice-cold PBS, blotted
dry and chopped finely with scissors in
1 vol of ice-cold tricine buffer and homo-
genized. The cell and thymic homogenates
were centrifuged at 105,000 g at 40C for
1 h and duplicate aliquots of cytosol (0 4 ml)
incubated at 00C with varying concentrations
of [1, 2(n)-3H]-dexamethasone (19-29 Ci/
mmol; Radiochemical Centre, Amersham) in
the presence or absence of a 1000-fold excess
of non-radioactive dexamethasone (Sigma).
Unbound steroid was removed after 2 h
by addition of 50-100 ,ul activated charcoal
(200 mg/ml; BDH Chemicals), which was
vigorously agitated for 5 sec and centrifuged
(600 g for 1 min). The supernatant was
recentrifuged (10,000 gfor 5 min) and aliquots
(200 ,ul) of supernatant assayed for radio-
activity in a toluene-based scintillant con-
taining Triton X-100 (33% v/v; Inter-
technique) and butyl-PBD (5 g/l; Intertech-
nique) in a Beckman LS-250 liquid scintilla-
tion spectrometer (efficiency -30%). Speci-
fically bound dexamethasone represents the
difference in amount of 3H-dexamethasone
bound to cytosol in the absence and presence
of 1000-fold excess ofnon-radioactive steroid.
Protein concentration was measured by the
technique of Lowry et al. (1951) using bovine
serum albumin as standard.
Cytolethal tests.-Duplicate cultures of
cells (3-5 x 105/ml) were grown in MEM
supplemented with 20% heat-inactivated
FCS at 370C in a humidified atmosphere
of 5% C02 in air. After 48 h when cells
were in log phase of growth, methyl predni-
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solone sodium succinate (Solumedrone, Up-
john) was added in aqueous solution at
concentrations between 10-7 and 10-3 mol/l
(final volume 1%). After incubation for a
further 48 h, the total number of cells was
enumerated with a haemacytometer and the
viability assessed by exclusion of nigrosine
(0 25%). Per cent lysis was calculated by
comparison with control cultures which
received no steroid.
RNA synthesis.-The effect of predni-
solone on the incorporation of (5-3H)-uridine
(3HU; 27 Ci/mmol; Radiochemical Centre,
Amersham) into the acid-insoluble fraction
of cells was estimated. Duplicate cultures
of cells (3-5 x 105/ml) were grown as
described above. Solumedrone was added
at concentrations between 10-6 and 10-3
mol/l to duplicate 1-0 ml aliquots of cells
and after 1 h these were pulsed with 10
,uCi/ml 3HU for 20 min. The cells were
collected in microfibre glass filters in a
sampling manifold (Millipore), precipitated
with ice-cold 5% trichloroacetic acid (3 x 10
ml) and washed with ice-cold 70% ethanol
(3 x 10 ml). Filters were dried at 37°C
and assayed for radioactivity in a toluene-
based scintillant containing butyl-PBD (5 0
g/l) in a Beckman LS-250 liquid scintillation
spectrometer (efficiency , 30%). Results
are expressed as incorporation of 3HU into
the acid insoluble fraction/106 viable cells.
RESULTS
Origin and karyotype of lymphoblastoid
cell lines
The origin, karyotype and age in
vitro of the 8 cell lines used in our
studies are shown in Table I. Whereas
there was some variation in chromosome
constitution within each line, there was
always a clear modal karyotype. Four
lines-RUS1, RUS2, PEN2 and YAK1-
had only minor alterations to the normal
diploid human complement, but the
others had multiple breakages and recom-
binations, including fragments and ab-
normal chromosomes the precise origin
of which could not be established.
Glucocorticoid cytoplasmic receptors in
lymphoblastoid cell lines
In steroid binding studies specific
receptors in the cytoplasmic extracts
(cytosol) of lymphoblastoid cells became
saturated with dexamethasone at con-
centrations above 5-8 x 10-8 mol/l as
illustrated in Fig. 1. Scatchard (1949)
analysis of the data, shown in the insert
of Fig. 1, yields a straight line consistent
with a single class of receptor molecules
TABLE I.-Origin, Karyotype, Age in Culture and Cytoplasmic Receptor Concentration
of Human Lymphoblastoid Cell Lines
Origin
Acute myeloblastic
leukaemia
Acute myeloblastic
leukaemia
Acute lymphoblastic
leukaemia
Subacute lymphatic
leukaemia
Chronic lymphatic
leukaemia
Burkitt's lymphoma
Adult blood*
Cord blood
Rat+
Modal karyotype
46 XY 18p+
46 XY 3/8 Translocation
46 XY Multiple breakages and
recombinations
48 XY Multiple breakages and
recombinations
48 XX Multiple breakages and
recombinations
Near tetraploid. Multiple
breakages and
recombinations
48 X$Y 14+
47 XY Partial trisomy 4
Age in
culture
(mth)
27
27
34
94
73
96
24
17
Specifically bound
dexamethasone
(pmol/mg
protein)
0 82
0 66
0 62
0*16
0 71
0 43
009
0 37
0 33
The results shown are the mean of 2 separate determinations.
* Klinefelter's syndrome. + Female PVG/C rats aged 88 days.
Cell line
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FIG. 1.-Specific binding of dlexamethasone to cell-free extracts of human lymphoblastoid cell lines
and rat thymus. Each point represents the mean of 3 separate experiments. The insert shows
Scatchard plots of the data. 0 O, RUS2 cells;O GS1 cells; x - * -* - x, rat thymus.
of uniform steroid affinity. The equi-
librium (dissociation) constants for the
2 examples shown, calculated from the
intercepts of the reciprocal plots, were
1 0 x 10-8 mol/l (RUS2) and 2 3 x 10-8
mol/l (GCS1). For comparison, Fig. 1
shows also the binding of dexamethasone
to cytoplasmic receptors of fresh rat
thymus, a tissue of ki,own high sensitivity
to the cytolytic effects of glucocorticoid
hormones in vivo (Dougherty and White,
1945); saturation occurred at similar con-
centrations of steroid, and the dissocia-
tion constant (3.7 X 10-8 mol/l) was of
similar magnitude.
Further characterization of lympho-
blastoid cell receptors revealed that they
were thermolabile and completely in-
activated by 30 min pre-incubation at
37°C. Similarly, incubation for 10 min
at 20°C with trypsin (1 mg/ml) and
protease (1 mg/ml) destroyed the binding
capacity of cytosol. Incubation with
deoxyribonuclease (bovine pancreas, 100
pg/ml) and ribonuclease (bovine pancreas,
100 ,ig/ml) had no significant effect on
the binding characteristics. Thus, the
cytoplasmic glucocorticoid receptors of
human lymphoblastoid cells appear to
be of a protein nature similar to those
described in other glucocorticoid sensitive
tissues (Hackney et al., 1970; Munck
and Wira, 1971; Baxter and Tomkins,
1971).
Using the competitive binding assay
at saturating concentrations of dexa-
methasone (8 x 10-8 mol/l), the relative
concentration of receptors in the cytosols
of the various cell lines was determined.
As shown in Table I a gradation in
receptor concentration was found. The
highest levels (0 62-0582 pmol/mg protein)
occurred in cell lines derived from patients
with acute leukaemia and from one case
of chronic lymphatic leukaemia, whilst
intermediate concentrations (0 37-0A43
pmol/mg protein) were found in lines
derived from a Burkitt's lymphoma and
a healthy placental cord blood. The
lowest levels (0-09-0 16 pmol/mg protein)
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FIG. 2. Cytolytic effect of prednisolone on human lymphoblastoil cell lines. Per celnt lysis was
calculated by comparison with control cultures which receive(I no steroidl. Each point represents
the mean of 2 separate experiments.
were found in the lines derived from a
patientwithsubacute lymphaticleukaemia
and from the peripheral blood of a non-
leukaemic adult patient. The concentra-
tion of receptors (0.33 pmol/mg protein)
in the fresh rat thymus corresponded
to the intermediate values obtained in the
cell lines.
Glucocorticoid cytolethal response
The lethal response was assessed mor-
phologically by the ability of cells to
exclude the dye nigrosine, following in-
cubation with aqueous preparations of
steroid for 48 h. As shown in Fig. 2, a
mild lethal response (10-15oo of cells)
was observed with prednisolone at con-
centrations of 10--10-4 mol/l although
these effects were apparently not in
direct proportion to absolute concentra-
tions of steroid. A marked increase in
the cytolethal effect was observed, how-
ever, when the steroid concentration was
increased to 10-3 mol/l and in some
instances more than 850 of cells were
killed. The magnitude of this enhanced
lethal response, however, did not corre-
late with the measured levels of specific
cytoplasmic hormone receptors, and some
of the cell lines with low receptor con-
centration appeared to be as sensitive as
those with high receptor levels (compare
Fig. 2 and Table I). The cell line derived
from Burkitt's lymphoma, however, was
notably resistant to lethal effects even
with high doses of steroid. Table I and
Fig. 2 show also that no correlation
could be established between steroid
receptor levels or sensitivity to cytolytic
effects and criteria which may be related
to the malignant " potential " of lympho-
blastoid cells in vivo, namely the origin
of the cells (from malignant or non-malig-
nant conditions), the degree of abnor-
mality of modal karyotype or the age
of cells in vitro.
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(10-3 mol/l) required to achieve severe
lethal effects exceeds physiological plasma
levels of steroid (10-6-10- mol/l) by
several orders of magnitude. Moreover,
as can be seen in Fig. 1, it is considerably
in excess of steroid concentrations re-
quired to saturate receptors in cytoplasmic
extracts. However, when other gluco-
corticoid hormones such as eortisol and
dexamethasone were tested over the same
concentration range virtually the same,
or in some cases somewhat reduced,
lethal effects were obtained, and no
significant differences were observed when
steroids soluble in ethanol or dimethyl-
sulphoxide were substituted for aqueous
preparations. Furthermore, destruction
of transcortin binding activity of serum
with heat (560C for 1 h) did not reduce
the lethal response obtained with cortisol
or prednisolone.
Ultrastructural studies of cultures
treated with 10-3 mol/l prednisolone
showed that less than 3% of steroid-
treated cells contained EBV particles and
the cytolethal effects could not be attri-
buted to induction of virus lytic cycle.
Cytolethal tests were also performed
with lymphoblasts isolated from the
peripheral blood of 6 patients with ALL
before commencement of therapy. De-
spite an apparent satisfactory clinical
response to chemotherapy which included
prednisolone, these cells did not show
any greater sensitivity to the lethal
effects of glucocorticoids in vitro than the
cultured lymphoblasts. Insufficient ma-
terial was available, however, to estimate
the receptor levels in these cells.
Glucocorticoid effect on RNA synthesis
The effect of prednisolone on the
incorporation of 3HU into the cold acid-
insoluble fraction of lymphoblastoid cells
was studied as an earlier and more
sensitive index of cell damage than
nigrosine. Preliminary investigations
showed that significant inhibition of 3HU
incorporation could be detected within
1 h of addition of prednisolone. Similar
results were observed in all the cell lines
TABLE II.-Effect of Prednisolone on
Incorporation of 3H-uridine into Human
Lymphoblastoid Cell Lines
Cell
line
RUSl
RUS2
BLA,
F89
GS1
JIJOYE
PEN2
YAK1
Control
incorporation
(ct/min/106
viable cells)
2975
7254
13152
17743
5539
45620
12630
15571
Fractional incorporation
of control
Prednisolone
concentration (mol/l)
10-6 10-5 10-4 10-3
0-99 0 89 0-72 0 23
090 0-81 0-56 0-15
0 87 0 79 0 47 0 09
1-02 0-86 0-58 0-13
0-87 0-84 0-63 0-19
0-88 0-83 0-68 0-16
0-89 0-88 0-60 0-11
0-91 0-86 0-64 0-15
The results shown are the mean of two separate
determinations and represent incorporation of
3H-uridine into the acid-insoluble fraction/106 viable
cells.
studied, including the Burkitt's lymphoma
cell line, as shown in Table II, irrespective
of their specific cytoplasmic receptor
concentration: thus, 1 h after addition
of 10-5 and 10-6 mol/l steroid there was
a slight reduction (<20%) in 3HU incor-
poration; with 10-4 mol/l prednisolone
moderate reductions (30-50%) were ob-
served whilst addition of 10-3 mol/l
steroid produced a marked inhibition
(>75%) of 3HU incorporation in all
cell lines.
DISCUSSION
In contrast to the findings in vivo
with lymphoblastoid cells ofALL patients
(Lippman et al., 1973), our results clearly
show that the level of specific cytoplasmic
receptors in human lymphoblastoid cells
cannot be used to predict their responsive-
ness to glucocorticoid treatment in vitro.
Similar responses to steroid treatment
were obtained with all but one of the
cell lines despite widely varying levels
of cytoplasmic receptors: the exception
was a cell line derived from Burkitt's
lymphoma, although it showed a similar
response to inhibition of RNA synthesis
as the other cell lines. It is noteworthy
that in our studies significant lethal
effects were observed only with doses
of steroid which produced a severe re-
duction (>75%) in incorporation of RNA
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precursors. Other workers (Rosen et al.,
1972; Stevens, Stevens and Hollander,
1974) have claimedthat smallerreductions
in RNA synthesis are associated with
impending lethal effects, although their
experiments did not include morpho-
logical observations of cell death.
Although failure to exclude nigrosine
is a rather insensitive test of cytolethal
damage since it occurs late in the process
of cell death, other techniques which
employ release of specific radiolabels
from damaged cells measure similar late
phenomena and are associated with in-
herent interpretative difficulties due to
" spontaneous " release of label (5'chro-
mium) or internal radiation effects
(125 iododeoxyuridine).
When compared with rodent lymph-
oma cell lines, human lymphoblastoid
cells appear relatively insensitive to the
lethal effects of glucocorticoids in vitro.
Rodent lymphoma cell lines (Harris,
1970; Rosenau et al., 1972; Turnell,
Clarke and Burton, 1973; Kondo, Kikuta
and Noumura, 1975), nearly always show
marked lethal responses to concentrations
of glucocorticoids in the physiological
range (10-6-10-7 mol/l) and thus may
differ fundamentally in their biological
responsiveness to steroid hormones.
The failure to correlate cytoplasmic
receptor levels with glucocorticoid re-
sponses, and the requirement ofpharmaco-
logical doses of steroid for substantial
cytolethal effects, suggest that cyto-
plasmic receptors may not be responsible
for initiation of the lethal glucocorticoid
effects we have observed in human
lymphoblastoid cells. Alternatively,
some form of steroid resistance may have
developed during the long period of
cultivation of cells in vitro. However,
in our hands freshly isolated lymphoblasts
from ALL patients showed a similar
resistance to lethal glucocorticoid effects in
vitro. It is possible, therefore, that de-
fects in activation of glucocorticoid cyto-
lethal methanisms may occur in lympho-
blastoid cells cultured in vitro for short
or long periods of time, rendering cells
insensitive to all but massive doses of
steroid.
Until recently, the emergence of re-
sistance to steroid effects has been attri-
buted to quantitative reductions in cyto-
plasmic receptor levels (Rosenau et al.,
1972; Lippman et al., 1973). Clearly, in
our cell lines this cannot account for
steroid resistance if present. However,
Sibley and Tomkins (1974) have recently
shown in studies with steroid-resistant
clones of mouse lymphoma cells that
whilst resistance to steroid effects results
predominantly from quantitative defi-
ciencies in steroid receptors, other more
subtle defects in hormone activation may
occur. Thus, resistance may result from
qualitative defects in cytoplasmic re-
ceptor molecules or reduction in the
capacity for transfer of formed steroid
receptor complexes to the nucleus. Rare-
ly, defects in the specific localization
of complexes within the nucleus appear
to occur since nuclear binding of steroid
receptor complexes did not provoke a
lethal response in some clones.
It is evident, therefore, that the
binding of steroids to cytoplasmic re-
ceptors represeiits only one stage of a
complex series of events leading to ex-
pression of hormone effects. It remains
to be seen whether the activation of
steroids in human lymphoblastoid cells in
vitro differs fundamentally from that
occurring in vivo. It seems likely, how-
ever, that analysis of each step in the
activation process will be required before
the potential responsiveness of cells to
glucocorticoid hormones can be predicted
accurately.
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